Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Treatment of multiple sclerosis with anti-CD20 antibodies.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
The history of the oxazaphosphorine cytostatics.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
[Infections and fingolimod].
CNS myelin wrapping is driven by actin disassembly.
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
2nd Annual Congress on Neurology and Epidemiology
Calcitriol Modulates the CD46 Pathway in T Cells.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.

Pages